We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARKF icon
6151
ARK Blockchain & Fintech Innovation ETF
ARKF
$761M
$73K ﹤0.01%
3,032
+2,966
+4,494% +$67.9K
PRT
6152
PermRock Royalty Trust Unit
PRT
$27.1M
$73K ﹤0.01%
13,531
-19,142
-59% -$123K
SMCP
6153
DELISTED
AlphaMark Actively Managed Small Cap ETF
SMCP
$73K ﹤0.01%
+2,856
New +$68.7K
DBS
6154
DELISTED
Invesco DB Silver Fund
DBS
$73K ﹤0.01%
2,849
-299
-9% -$7.54K
AKRO
6155
DELISTED
Akero Therapeutics
AKRO
$72K ﹤0.01%
3,261
-2,847
-47% -$58.9K
CRAK icon
6156
VanEck Oil Refiners ETF
CRAK
$253M
$72K ﹤0.01%
2,484
+1,348
+119% +$39.5K
DRRX
6157
DELISTED
DURECT Corp
DRRX
$72K ﹤0.01%
1,898
+1,192
+169% +$24.6K
ICL icon
6158
ICL Group
ICL
$6.85B
$72K ﹤0.01%
15,213
-12,903
-46% -$59.6K
RSF
6159
RiverNorth Capital and Income Fund
RSF
$58.9M
$72K ﹤0.01%
4,006
+3,305
+471% +$60.1K
RSG icon
6160
PUT
Republic Services
RSG
$65.7B
$72K ﹤0.01%
800
+400
+100% +$35K
WEAT icon
6161
Teucrium Wheat Fund
WEAT
$292M
$72K ﹤0.01%
2,453
+881
+56% +$24.3K
HYB
6162
DELISTED
New America High Income Fund, Inc.
HYB
$72K ﹤0.01%
7,936
-4,030
-34% -$36.2K
HEWC
6163
DELISTED
iShares Currency Hedged MSCI Canada ETF
HEWC
$72K ﹤0.01%
2,683
+51
+2% +$1.38K
TTCF
6164
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
$72K ﹤0.01%
7,055
+5,455
+341% +$55.5K
TEUM
6165
DELISTED
Pareteum Corporation
TEUM
$72K ﹤0.01%
165,767
+83,637
+102% +$48.3K
ACRS icon
6166
Aclaris Therapeutics
ACRS
$869M
$71K ﹤0.01%
37,806
+28,749
+317% +$47.6K
CLSD
6167
DELISTED
Clearside Biomedical
CLSD
$71K ﹤0.01%
1,643
-1,182
-42% -$24.8K
PLCE icon
6168
Children's Place
PLCE
$59.8M
$71K ﹤0.01%
1,136
+621
+121% +$45.3K
WBIY icon
6169
WBI Power Factor High Dividend ETF
WBIY
$62.7M
$71K ﹤0.01%
2,680
+425
+19% +$10.8K
HNP
6170
DELISTED
Huaneng Power Intl, Inc.
HNP
$71K ﹤0.01%
3,534
-1,040
-23% -$20.1K
LN
6171
DELISTED
LINE Corporation
LN
$71K ﹤0.01%
1,433
-102
-7% -$4.36K
CHAP
6172
DELISTED
Chaparral Energy, Inc.
CHAP
$71K ﹤0.01%
39,952
+13,494
+51% +$13.6K
IMFC
6173
DELISTED
Invesco Multi-Factor Core Fixed Income ETF
IMFC
$71K ﹤0.01%
2,753
+1,283
+87% +$33.6K
DGAZ
6174
DELISTED
VelocityShares 3x Inverse Natural Gas ETN linked to the S&P GSCI Natural Gas Index Excess Return
DGAZ
$71K ﹤0.01%
+388
New +$54K
ALFA
6175
DELISTED
AlphaClone Alternative Alpha ETF
ALFA
$71K ﹤0.01%
+1,207
New +$68.3K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.